biodefense News
Most Popular biodefense Story
Avant, Celldex merge in $115M stock deal
Avant Immunotherapeutics is merging with Celldex Therapeutics in a stock deal valued at $115 million. Celldex shareholders will wind up with a majority of the shares in the merged company, which will... Read more...
Latest Headlines
- October 22, 2007
- January 21, 2007
- January 8, 2007
- January 8, 2007
- December 20, 2006
- October 4, 2006
- September 27, 2006
- September 27, 2006
- August 14, 2006
- July 20, 2006
- June 19, 2006
- June 8, 2006
- April 9, 2006
- March 13, 2006
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
